Literature DB >> 23997080

A novel subtype of myeloproliferative disorder? JAK2V617F-associated hypereosinophilia with hepatic venous thrombosis.

Sowjanya Dasari1, Kushal Naha, Manjunath Hande, G Vivek.   

Abstract

We report the case of a 27-year-old man, presenting with one episode of massive haematemesis and a history of persistent eosinophilia for the past 8 months. An evaluation revealed hepatic cirrhosis with portal hypertension, secondary to chronic Budd-Chiari syndrome. Further investigations confirmed a diagnosis of hypereosinophilic syndrome. Molecular genetic analysis was negative for FIP1L1-PDGFRA gene rearrangement, but positive for JAK2V617F mutation.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23997080      PMCID： PMC3762390          DOI： 10.1136/bcr-2013-200087

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  9 in total

Review 1.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

2.  Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.

Authors:  Amy V Jones; Sebastian Kreil; Katerina Zoi; Katherine Waghorn; Claire Curtis; Lingyan Zhang; Joannah Score; Rachel Seear; Andrew J Chase; Francis H Grand; Helen White; Christine Zoi; Dimitris Loukopoulos; Evangelos Terpos; Elisavet-Christine Vervessou; Beate Schultheis; Michael Emig; Thomas Ernst; Eva Lengfelder; Rüdiger Hehlmann; Andreas Hochhaus; David Oscier; Richard T Silver; Andreas Reiter; Nicholas C P Cross
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

3.  Hypereosinophilia, JAK2V617F, and Budd-Chiari syndrome: who is responsible for what?

Authors:  Elena Mishchenko; Tamar Tadmor; Elad Schiff; Dina Attias; Aaron Polliack
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

4.  Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.

Authors:  Amarapurkar Deepak; Sundeep Punamiya; Nikhil Patel; Sunil Parekh; Shilpa Mehta; Nirali Shah
Journal:  Trop Gastroenterol       Date:  2011 Oct-Dec

Review 5.  Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

Authors:  Jasper H Smalberg; Lidia R Arends; Dominique C Valla; Jean-Jacques Kiladjian; Harry L A Janssen; Frank W G Leebeek
Journal:  Blood       Date:  2012-10-04       Impact factor: 22.113

6.  Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation.

Authors:  G Helbig; B Stella-Holowiecka; M Majewski; M Lewandowska; J Holowiecki
Journal:  Haematologica       Date:  2007-11       Impact factor: 9.941

7.  Screening for JAK2 V617F point mutation in patients with hypereosinophilic syndrome-in response to 'Hypereosinophilic syndrome: another face of janus?' by Dahabreh et al. published in Leukemia Research, in press.

Authors:  Grzegorz Helbig; Mirosław Majewski; Agata Wieczorkiewicz; Grazyna Bober; Janina Grzegorczyk; Joanna Dziaczkowska-Suszek; Anna Soja; Aleksandra Bartkowska-Chrobok; Małgorzata Krawczyk; Sławomira Krzemień
Journal:  Leuk Res       Date:  2008-05-07       Impact factor: 3.156

8.  Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

Authors:  Princess U Ogbogu; Bruce S Bochner; Joseph H Butterfield; Gerald J Gleich; Johannes Huss-Marp; Jean Emmanuel Kahn; Kristin M Leiferman; Thomas B Nutman; Florian Pfab; Johannes Ring; Marc E Rothenberg; Florence Roufosse; Marie-Helene Sajous; Javed Sheikh; Dagmar Simon; Hans-Uwe Simon; Miguel L Stein; Andrew Wardlaw; Peter F Weller; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 9.  Hypereosinophilic syndromes.

Authors:  Jean-Emmanuel Kahn; Olivier Blétry; Loïc Guillevin
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-10       Impact factor: 4.098
  9 in total
  3 in total

1.  Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction.

Authors:  Praveer Rai; Pankaj Kumar; Swapnil Mishra; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2016-09-16

2.  BRAF mutation as a novel driver of eosinophilic cystitis.

Authors:  Michael Y Choi; Igor F Tsigelny; Amelie Boichard; Åge A Skjevik; Ahmed Shabaik; Razelle Kurzrock
Journal:  Cancer Biol Ther       Date:  2017-08-22       Impact factor: 4.742

3.  Possible interesting link between Janus kinase 2 mutation and renovascular hypertension.

Authors:  Kouichi Tamura; Kotaro Haruhara; Kengo Azushima; Tamio Iwamoto; Hiromichi Wakui
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-14       Impact factor: 3.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.